PLAT and acute respiratory distress syndrome: Indeed, infusion of tissue-type plasminogen activators has been revealed useful in severe SARS-CoV-2 infected patients [95], and current clinical trials on ARDS-related conditions are in progress with SARS-CoV-2 infected patients (NCT04357730).